Published in Riv Psichiatr on November 26, 2014
Long-term treatment with antidepressant drugs: the spectacular achievements of propaganda. Psychother Psychosom (2002) 2.11
Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom (2010) 2.08
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom (2013) 1.73
The biopsychosocial model thirty years later. Psychother Psychosom (2007) 1.68
Childhood abuse and later medical disorders in women. An epidemiological study. Psychother Psychosom (2002) 1.57
Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom (2004) 1.51
Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50
Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom (2014) 1.46
Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom (2013) 1.43
Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Int J Neuropsychopharmacol (2007) 1.39
The biopsychosocial factor. Psychother Psychosom (2011) 1.38
Unmasking special interest groups: the key to addressing conflicts of interest in medicine. Psychother Psychosom (2010) 1.38
Increasing psychological well-being and resilience by psychotherapeutic methods. J Pers (2009) 1.34
The concept of recovery in major depression. Psychol Med (2007) 1.27
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom (2015) 1.16
The cult of mediocrity. Psychother Psychosom (2005) 1.15
Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Psychother Psychosom (2005) 1.04
Psychological aspects of traumatic injury in children and adolescents. Child Adolesc Psychiatr Clin N Am (2003) 1.03
Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry (2005) 1.03
Staging of mental disorders: systematic review. Psychother Psychosom (2012) 0.98
Well-being therapy in school settings: a pilot study. Psychother Psychosom (2006) 0.97
The road to recovery from depression--don't drive today with yesterday's map. Psychother Psychosom (2007) 0.97
New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs (2010) 0.97
Role of well-being therapy in achieving a balanced and individualized path to optimal functioning. Clin Psychol Psychother (2012) 0.97
The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry (2011) 0.95
Factors associated with dropout from treatment for eating disorders: a comprehensive literature review. BMC Psychiatry (2009) 0.95
Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety (2010) 0.94
Mania associated with venlafaxine discontinuation. Int J Neuropsychopharmacol (2003) 0.94
Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord (2010) 0.93
School intervention for promoting psychological well-being in adolescence. J Behav Ther Exp Psychiatry (2009) 0.91
Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) (2007) 0.91
Well-being therapy for generalized anxiety disorder. J Clin Psychol (2009) 0.91
The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom (2008) 0.90
Information overload, the patient and the clinician. Psychother Psychosom (2007) 0.90
The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom (2011) 0.89
Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess (2007) 0.88
The relationship of psychological well-being to distress and personality. Psychother Psychosom (2003) 0.88
Differences in depressive thoughts between major depressive disorder, IFN-alpha-induced depression, and depressive disorders among cancer patients. J Psychosom Res (2008) 0.88
A different medicine is possible. Psychother Psychosom (2006) 0.87
Factors affecting interindividual differences in clozapine response: a review and case report. Hum Psychopharmacol (2011) 0.86
The unifying concept of illness behavior. Psychother Psychosom (2012) 0.86
ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review. Neuropsychiatr Dis Treat (2012) 0.86
The role of cerebellum in unipolar and bipolar depression: a review of the main neurobiological findings. Riv Psichiatr (2014) 0.86
Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom (2005) 0.85
Smoking behaviour and mental health disorders--mutual influences and implications for therapy. Int J Environ Res Public Health (2013) 0.85
Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord (2006) 0.84
Psychological aspects of primary aldosteronism. Psychother Psychosom (2006) 0.84
Circadian blood pressure patterns and life stress. Psychother Psychosom (2002) 0.84
Subtyping depression in the medically ill by cluster analysis. J Affect Disord (2011) 0.83
Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders. Am J Psychiatry (2007) 0.83
A discussion on the role of clinimetrics and the misleading effects of psychometric theory. J Clin Epidemiol (2005) 0.82
How citation analysis can monitor the progress of research in clinical medicine. Psychother Psychosom (2004) 0.81
Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab (2011) 0.81
Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am (2012) 0.81
Protective environments and health status: cross-talk between human and animal studies. Neurobiol Aging (2005) 0.81
Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) (2006) 0.81
Psychological assessment in cardiac rehabilitation. Psychother Psychosom (2003) 0.81
Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatry. Curr Psychiatry Rep (2010) 0.81
Assessing the community prevalence of bipolar spectrum symptoms by the mood disorder questionnaire. Psychother Psychosom (2005) 0.80
P300 component in euthymic patients with bipolar disorder type I, bipolar disorder type II and healthy controls: a preliminary event-related potential study. Neuroreport (2015) 0.80
The clinical factor. Psychother Psychosom (2010) 0.79
Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry (2013) 0.79
Psychological characterization of demoralization in the setting of heart transplantation. J Clin Psychiatry (2010) 0.79
Differential effects of well-being promoting and anxiety-management strategies in a non-clinical school setting. J Anxiety Disord (2010) 0.79
Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde? Psychother Psychosom (2003) 0.78
[Stressful life events and depressive disorders as risk factors for acute coronary heart disease]. Ital Heart J Suppl (2005) 0.78
Irritable mood in Italian patients with medical disease. J Nerv Ment Dis (2006) 0.78
The need for a behavioural science focus in research on mental health and mental disorders. Int J Methods Psychiatr Res (2014) 0.78
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother Psychosom (2016) 0.78
Two key concepts in the life course approach in medicine: allostatic load and cumulative life course impairment. Curr Probl Dermatol (2013) 0.77
Use of the Diagnostic Criteria for Psychosomatic Research (DCPR) in a community sample. Psychosomatics (2006) 0.77
Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders. Psychother Psychosom (2012) 0.77
Kellner's emotional inhibition scale: a clinimetric approach to alexithymia research. Psychother Psychosom (2011) 0.77
The Clinical Interview for Depression: a comprehensive review of studies and clinimetric properties. Psychother Psychosom (2010) 0.77
Family intervention approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. J Clin Psychiatry (2007) 0.77
Psychosocial approach to endocrine disease. Adv Psychosom Med (2007) 0.77
Residual symptoms in depression an emerging therapeutic concept. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.77
Assessing somatization with various diagnostic criteria. Psychosomatics (2009) 0.76
[Promoting psychosocial well-being in adolescence. A controlled study]. Riv Psichiatr (2012) 0.76
Assessing psychological factors affecting medical conditions: comparison between different proposals. Gen Hosp Psychiatry (2012) 0.76
Improving the concept of recovery in endocrine disease by consideration of psychosocial issues. J Clin Endocrinol Metab (2012) 0.76
[Hikikomori (ひきこもり): a culture-bound syndrome in the web 2.0 era]. Riv Psichiatr (2013) 0.76
Modern psychiatric treatment: a tribute to Thomas Detre, MD (1924-2011). Psychother Psychosom (2012) 0.76
Development of a new assessment strategy in psychosomatic medicine: the diagnostic criteria for psychosomatic research. Adv Psychosom Med (2007) 0.76
Nowhere patients. Psychother Psychosom (2012) 0.76
Rehabilitation in endocrine patients: a novel psychosomatic approach. Psychother Psychosom (2007) 0.76
Reply: To PMID 22964522. Psychother Psychosom (2013) 0.75